Skip to main content
Premium Trial:

Request an Annual Quote

GNF to Use Ingenuity Pathways Analysis Technology

NEW YORK, Nov. 24 (GenomeWeb News) - Ingenuity Systems said today that its Pathways Analysis application has been licensed for research use by the Genomics Institute of the Novartis Research Foundation.

 

The Pathways Analysis system maps relationships between proteins, genes, complexes, cells, tissues, drugs, and diseases.

 

Terms of the deal were not disclosed.

 

Ingenuity has recently licensed the Pathways Analysis system to the Stanford Genome Technology Center and GlaxoSmithKline, and recently signed a software distribution deal with investor Affymetrix.

The Scan

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.

New Insights Into TP53-Driven Cancer

Researchers examine in Nature how TP53 mutations arise and spark tumor development.

Mapping Single-Cell Genomic, Transcriptomic Landscapes of Colorectal Cancer

In Genome Medicine, researchers present a map of single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer.

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.